Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Law and Government

^GSPC Today: Iran Plot Trial Lifts Geopolitical Risk – March 4

March 4, 2026
5 min read
Share with:

The Iran assassination plot trial is back in focus and raising a geopolitical risk premium. For Australian investors, headline risk around an IRGC-linked case can sway the S&P 500 (^GSPC) and global risk appetite. Our latest feed shows the index near 6,816, with softer momentum and wider intraday ranges. We outline what the trial means, why risk is sticky, and how to set levels and hedges in AUD terms without overreacting to every headline.

What the trial means for markets today

U.S. prosecutors allege links between the IRGC and a foiled 2024 plot that eyed Donald Trump. Coverage outlines a case built on messages, meetings, and surveillance that prosecutors say tie intermediaries to Tehran’s network. See detailed accounts in The New York Times source and AP via Yahoo News source. The court process, not the verdict alone, can move risk pricing if new facts surface.

Sponsored

The Iran assassination plot trial adds policy and security unknowns. Traders often mark up defense, cyber, and energy risk. This can lift equity volatility and compress valuation multiples, even without direct earnings hits. Markets also watch for sanctions talk or diplomatic strain. Each filing, witness note, or leak becomes a catalyst, lifting the geopolitical risk premium and nudging investors toward cash, gold, or short-duration bonds.

S&P 500 setup: levels, momentum, and risk

At last recorded print, ^GSPC was 6,816.62, down 0.94% on the day, with a 6,710.42–6,840.05 range. Year-to-date is -0.61%, 1-year +16.53%, 3-year +68.49%, 10-year +241.96%. Average true range is 88, pointing to wider swings. Volume sits below average. The Iran assassination plot trial keeps sensitivity high, so intraday gaps around filings or headlines are more likely than usual.

RSI is 42.83, below neutral. MACD is -10.76 vs signal -6.72, and ADX is 16.95, showing no strong trend. Bollinger bands center on 6,885.20, with lower at 6,792.57. Keltner lower is 6,711.16. CCI is -185.31, an oversold read. The 50-day average is 6,901.50; the 200-day is 6,564.90. Composite grade: C+ (score 58.57), suggestion: HOLD.

Why Australian investors should care

Risk-off in the S&P 500 often narrows appetite for growth, weighs on cyclicals, and can lift the USD against the AUD. Many super funds and ETFs hold large U.S. equity weights, so U.S. shocks pass through to Australian balances. The Iran assassination plot trial also adds event risk to options pricing, increasing hedging costs that global allocators factor into rebalancing.

Any sign of sanctions or regional friction can push crude higher, adding to inflation stickiness. That mix can lift global yields and pressure equity valuations. For Australia, higher oil and LNG benchmarks feed into fuel and freight costs. Watch central bank language on inflation risk, as the geopolitical risk premium can slow expected timing of rate cuts and cap equity multiples.

Portfolio moves to consider now

Keep a simple plan. Map core equity risk to ATR and your tolerance. Use staggered limit orders and alerts around 6,792–6,885 to avoid chasing moves. Currency-hedged global equity sleeves can reduce AUD swings. Consider light hedges via index exposure or cash buffers sized to the 88-point ATR. Review stop-loss levels ahead of key court days in the Iran assassination plot trial.

Base case: slow-drip headlines sustain a modest geopolitical risk premium. Upside risk: de-escalatory signals or a weak evidentiary link ease volatility. Downside risk: new facts tie actors more closely to state organs, lifting vol and oil. Key catalysts include court filings, sanctions talk, and energy supply news tied back to the Iran assassination plot trial.

Final Thoughts

The Iran assassination plot trial keeps headline risk elevated, which tends to trim multiples and lift day-to-day volatility. For Australians, the pass-through runs via the S&P 500, the AUD, and energy prices. Work with clear levels: note the Bollinger center near 6,885, the lower band near 6,793, and Keltner lower near 6,711. Use the 88-point ATR to size orders, stops, and hedges. Keep core positions steady while news is fluid, and rotate risk only when price confirms with improving momentum and breadth. This balanced approach respects geopolitical shocks without giving up long-term exposure.

FAQs

What is the Iran assassination plot trial and why does it matter for markets?

It is a New York case alleging links between the IRGC and a foiled 2024 plot that eyed Donald Trump. Trials can add policy and security unknowns that markets price as a geopolitical risk premium. That often raises volatility and can compress equity valuation multiples until the facts become clearer.

How could the Iran assassination plot trial affect the S&P 500 today?

Headlines can spark intraday gaps and wider ranges. With RSI at 42.83 and ATR at 88, the tape is sensitive. If new facts suggest higher state risk or sanctions talk, the index can face multiple compression. Calmer testimony or weak links can ease the geopolitical risk premium and firm sentiment.

What levels are most useful for near-term risk management on ^GSPC?

Watch the Bollinger center near 6,885 and lower band near 6,793, plus Keltner lower at 6,711. The 50-day average at 6,901 and 200-day at 6,565 frame trend context. Use the 88-point ATR to set stops, order spacing, and position size during the trial’s headline windows.

What should Australian investors monitor beyond the index itself?

Track crude and LNG benchmarks, AUD moves against USD, and any sanctions or policy commentary. These channels push inflation and rates, which drive valuation multiples. Also watch options pricing and hedging costs, as the geopolitical risk premium can lift implied volatility and change rebalancing plans.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)